An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology

Show simple item record Gingell, Joseph en Simms, J en Barwell, J en Poyner, DR en Watkins, HA en Pioszak, AA en Sexton, PM en Hay, Deborah en 2016-09-16T06:18:05Z en 2016-05-17 en
dc.identifier.citation Cell Discovery, 2016, 2: 16012, pp. 1 - 14 en
dc.identifier.uri en
dc.description.abstract G protein-coupled receptors are allosteric proteins that control transmission of external signals to regulate cellular response. Although agonist binding promotes canonical G protein signalling transmitted through conformational changes, G protein-coupled receptors also interact with other proteins. These include other G protein-coupled receptors, other receptors and channels, regulatory proteins and receptor-modifying proteins, notably receptor activity-modifying proteins (RAMPs). RAMPs have at least 11 G protein-coupled receptor partners, including many class B G protein-coupled receptors. Prototypic is the calcitonin receptor, with altered ligand specificity when co-expressed with RAMPs. To gain molecular insight into the consequences of this protein–protein interaction, we combined molecular modelling with mutagenesis of the calcitonin receptor extracellular domain, assessed in ligand binding and functional assays. Although some calcitonin receptor residues are universally important for peptide interactions (calcitonin, amylin and calcitonin gene-related peptide) in calcitonin receptor alone or with receptor activity-modifying protein, others have RAMP-dependent effects, whereby mutations decreased amylin/calcitonin gene-related peptide potency substantially only when RAMP was present. Remarkably, the key residues were completely conserved between calcitonin receptor and AMY receptors, and between subtypes of AMY receptor that have different ligand preferences. Mutations at the interface between calcitonin receptor and RAMP affected ligand pharmacology in a RAMP-dependent manner, suggesting that RAMP may allosterically influence the calcitonin receptor conformation. Supporting this, molecular dynamics simulations suggested that the calcitonin receptor extracellular N-terminal domain is more flexible in the presence of receptor activity-modifying protein 1. Thus, RAMPs may act in an allosteric manner to generate a spectrum of unique calcitonin receptor conformational states, explaining the pharmacological preferences of calcitonin receptor-RAMP complexes. This provides novel insight into our understanding of G protein-coupled receptor-protein interaction that is likely broadly applicable for this receptor class. en
dc.description.uri en
dc.publisher Nature Publishing Group en
dc.relation.ispartofseries Cell Discovery en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from en
dc.rights.uri en
dc.rights.uri en
dc.title An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology en
dc.type Journal Article en
dc.identifier.doi 10.1038/celldisc.2016.12 en
pubs.begin-page 1 en
pubs.volume 2 en
dc.description.version VoR – Version of Record en
dc.identifier.pmid 27462459 en en
pubs.end-page 14 en
pubs.publication-status Published en
dc.rights.accessrights en
pubs.subtype Article en
pubs.elements-id 530433 en Science en Biological Sciences en Science Research en Maurice Wilkins Centre (2010-2014) en
dc.identifier.eissn 2056-5968 en
pubs.number 16012 en
pubs.record-created-at-source-date 2016-09-16 en
pubs.dimensions-id 27462459 en

Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record


Search ResearchSpace